PROS1 and cancer: Common cancer biomarkers, such as prostate-specific antigen (PSA), carcinoembryonic antigen (CEA), CA 125, CA 19-9, and alpha-fetoprotein (AFP) [71], have been extensively studied for early cancer screening, diagnosis, and monitoring.